This archive covers progress in drug policy reform, psychedelic-assisted therapy, harm reduction, and the science behind entheogenic substances. From clinical trials to legal milestones, these stories track how researchers, policymakers, and communities are rethinking humanity’s relationship with mind-altering compounds.
Civica Rx is a joint effort by big names like Catholic Health Initiatives, HCA Healthcare, Intermountain Healthcare, Providence St. Joseph Health, the Mayo Clinic, SSM Health, and Trinity Health.
According to a new study from King’s College London (KCL), just one dose of CBD can reduce abnormal brain function in people with psychosis.
Recreational marijuana use will soon be legal in Canada after the Senate passed a “historic” bill on Tuesday with a vote of 52-29.
The City of Seattle on Friday filed a motion asking the court to vacate hundreds of marijuana possession convictions going back three decades and adversely impacting people of color.
Psychedelic therapy began in the early 1950s at a Saskatchewan psychiatric hospital, where Abram Hoffer and Humphrey Osmond gave LSD to patients struggling with alcoholism in carefully guided sessions. Osmond would later coin the word “psychedelic” in a 1957 letter to Aldous Huxley. Seven decades on, their prepare-administer-integrate framework is quietly reshaping modern psychiatry.
A codex known as the “Yuta Tnoho” that belonged to the Mixtec culture in the 1500s B.C.E. is the earliest historical record of psilocybin use in human history.
